Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.

Jin T, Almehed K, Carlsten H, Forsblad-d'Elia H.

Lupus. 2012 Mar;21(3):310-8. doi: 10.1177/0961203311425528. Epub 2011 Nov 9.

PMID:
22072025
2.

Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.

Manolova I, Gerenova J, Ivanova M.

Eur Cytokine Netw. 2013 Mar;24(1):69-74. doi: 10.1684/ecn.2013.0331.

3.

Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.

Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.

Eur Cytokine Netw. 2001 Jul-Sep;12(3):445-52.

4.

Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.

Heshmat NM, El-Kerdany TH.

Pediatr Allergy Immunol. 2007 Jun;18(4):346-53. Epub 2007 Mar 7.

PMID:
17346298
6.

Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.

Xing Q, Su H, Cui J, Wang B.

Immunol Invest. 2012;41(1):15-27. doi: 10.3109/08820139.2011.578189. Epub 2011 May 12.

PMID:
21563925
7.

Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.

Lu LY, Chu JJ, Lu PJ, Sung PK, Hsu CM, Tseng JC.

J Microbiol Immunol Infect. 2008 Apr;41(2):165-73.

PMID:
18473105
8.

Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.

El-Banawy HS, Gaber EW, Maharem DA, Matrawy KA.

J Nephrol. 2012 Jul-Aug;25(4):541-50. doi: 10.5301/jn.5000030.

PMID:
21956768
9.

Soluble E-cadherin in systemic lupus erythematosus.

Jin T, Almehed K, Zhu Y, Carlsten H, Forsblad-d'Elia H.

J Rheumatol. 2013 Oct;40(10):1677-82. doi: 10.3899/jrheum.130518. Epub 2013 Sep 1.

PMID:
23996289
10.

Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.

Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.

Arch Dermatol Res. 2006 Jan;297(7):329-32. Epub 2005 Nov 17.

PMID:
16328345
12.

Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.

Von Feldt JM, Scalzi LV, Cucchiara AJ, Morthala S, Kealey C, Flagg SD, Genin A, Van Dyke AL, Nackos E, Chander A, Gehrie E, Cron RQ, Whitehead AS.

Arthritis Rheum. 2006 Jul;54(7):2220-7.

13.

Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement.

Cheng Q, Hoi A, Hickey MJ, Morand EF.

Lupus. 2012 May;21(6):632-41. doi: 10.1177/0961203312436860. Epub 2012 Feb 16.

PMID:
22345121
14.

Role of resistin as a marker of inflammation in systemic lupus erythematosus.

Almehed K, d'Elia HF, Bokarewa M, Carlsten H.

Arthritis Res Ther. 2008;10(1):R15. doi: 10.1186/ar2366. Epub 2008 Jan 30.

15.

Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.

Brugos B, Kiss E, Dul C, Gubisch W, Szegedi G, Sipka S, Zeher M.

Hum Immunol. 2010 Sep;71(9):874-7. doi: 10.1016/j.humimm.2010.06.004. Epub 2010 Jun 9.

PMID:
20538031
16.

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.

Arthritis Rheum. 2006 Sep;54(9):2951-62.

17.

Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.

Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, Scholey J, Gladman DD, Urowitz MB, Fortin PR.

J Rheumatol. 2010 Aug 1;37(8):1667-72. doi: 10.3899/jrheum.091028. Epub 2010 Jun 1.

PMID:
20516026
18.

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.

Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group.

J Rheumatol. 2005 Nov;32(11):2150-5.

PMID:
16265693
20.

Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.

Ezzat M, El-Gammasy T, Shaheen K, Shokr E.

Lupus. 2011 Jul;20(8):845-54. doi: 10.1177/0961203311398513. Epub 2011 May 16.

PMID:
21576203

Supplemental Content

Support Center